Prelude Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,362
Closed -$877K 1183
2024
Q3
$877K Buy
+8,362
New +$978K 0.05% 428
2024
Q1
Sell
-1,788
Closed -$232K 1286
2023
Q4
$232K Sell
1,788
-1,555
-47% -$214K 0.02% 869
2023
Q3
$545K Buy
3,343
+1,598
+92% +$281K 0.04% 449
2023
Q2
$320K Sell
1,745
-635
-27% -$91.4K 0.02% 613
2023
Q1
$317K Buy
+2,380
New +$280K 0.02% 625
2020
Q4
Sell
-1,316
Closed -$29K 1223
2020
Q3
$29K Sell
1,316
-43
-3% -$1.1K ﹤0.01% 1254
2020
Q2
$38K Buy
+1,359
New +$33.1K ﹤0.01% 1225
2019
Q2
Sell
-637
Closed -$13K 1609
2019
Q1
$13K Hold
637
﹤0.01% 1371
2018
Q4
$11K Sell
637
-105
-14% -$1.87K ﹤0.01% 1352
2018
Q3
$15K Sell
742
-1,591
-68% -$32.8K ﹤0.01% 1362
2018
Q2
$46K Buy
+2,333
New +$51.3K ﹤0.01% 1136
2017
Q4
Sell
-1,700
Closed -$46K 1320
2017
Q3
$46K Buy
1,700
+210
+14% +$4.65K ﹤0.01% 1122
2017
Q2
$31K Buy
+1,490
New +$31.5K ﹤0.01% 1144
2015
Q4
Sell
-1,571
Closed -$17K 1425
2015
Q3
$17K Buy
1,571
+208
+15% +$2.53K ﹤0.01% 1265
2015
Q2
$16K Buy
+1,363
New +$15.8K ﹤0.01% 1474

Other funds holding ACLS

Prelude Capital Management's ACLS Position: Q4 2024 in Review

Prelude Capital Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 8,362 shares — an estimated $877K sold.

Prelude Capital Management first reported a position in ACLS in Q2 2015 and held it in 15 quarters. The position peaked at $877K in Q3 2024. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Prelude Capital Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 8,362 Axcelis shares in Q4 2024, an estimated $877K.
  • Prelude Capital Management first reported a position in Axcelis in Q2 2015 and held it in 15 quarters.
  • Prelude Capital Management's Axcelis position peaked at $877K in Q3 2024.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.